Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Melissa, Kerkhof"'
Autor:
Youri Hoogstrate, Kaspar Draaisma, Santoesha A. Ghisai, Levi van Hijfte, Nastaran Barin, Iris de Heer, Wouter Coppieters, Thierry P.P. van den Bosch, Anne Bolleboom, Zhenyu Gao, Arnaud J.P.E. Vincent, Latifa Karim, Manon Deckers, Martin J.B. Taphoorn, Melissa Kerkhof, Astrid Weyerbrock, Marc Sanson, Ann Hoeben, Slávka Lukacova, Giuseppe Lombardi, Sieger Leenstra, Monique Hanse, Ruth E.M. Fleischeuer, Colin Watts, Nicos Angelopoulos, Thierry Gorlia, Vassilis Golfinopoulos, Vincent Bours, Martin J. van den Bent, Pierre A. Robe, Pim J. French
Publikováno v:
Cancer Cell, 41(4)
Cancer Cell, 41(4), 678-692.e7. Cell Press
Hoogstrate, Y, Draaisma, K, Ghisai, S A, van Hijfte, L, Barin, N, de Heer, I, Coppieters, W, van den Bosch, T P P, Bolleboom, A, Gao, Z, Vincent, A J P E, Karim, L, Deckers, M, Taphoorn, M J B, Kerkhof, M, Weyerbrock, A, Sanson, M, Hoeben, A, Lukacova, S, Lombardi, G, Leenstra, S, Hanse, M, Fleischeuer, R E M, Watts, C, Angelopoulos, N, Gorlia, T, Golfinopoulos, V, Bours, V, van den Bent, M J, Robe, P A & French, P J 2023, ' Transcriptome analysis reveals tumor microenvironment changes in glioblastoma ', Cancer Cell, vol. 41, no. 4, pp. 678-692.e7 . https://doi.org/10.1016/j.ccell.2023.02.019
Cancer Cell, 41(4), 678-692.e7. Cell Press
Hoogstrate, Y, Draaisma, K, Ghisai, S A, van Hijfte, L, Barin, N, de Heer, I, Coppieters, W, van den Bosch, T P P, Bolleboom, A, Gao, Z, Vincent, A J P E, Karim, L, Deckers, M, Taphoorn, M J B, Kerkhof, M, Weyerbrock, A, Sanson, M, Hoeben, A, Lukacova, S, Lombardi, G, Leenstra, S, Hanse, M, Fleischeuer, R E M, Watts, C, Angelopoulos, N, Gorlia, T, Golfinopoulos, V, Bours, V, van den Bent, M J, Robe, P A & French, P J 2023, ' Transcriptome analysis reveals tumor microenvironment changes in glioblastoma ', Cancer Cell, vol. 41, no. 4, pp. 678-692.e7 . https://doi.org/10.1016/j.ccell.2023.02.019
A better understanding of transcriptional evolution of IDH-wild-type glioblastoma may be crucial for treatment optimization. Here, we perform RNA sequencing (RNA-seq) (n = 322 test, n = 245 validation) on paired primary-recurrent glioblastoma resecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bb4d868c4967f080400fdfa01b352cb
https://doi.org/10.1016/j.ccell.2023.02.019
https://doi.org/10.1016/j.ccell.2023.02.019
Autor:
Youri Hoogstrate, Santoesha Ghisai, Kaspar Draaisma, Vincent Bours, Jan Buter, Isabelle vanden Bempt, Marica Eoli, Enrico Franceschi, Jean-Sebastien Frenel, Thierry Gorlia, Monique Hanse, Ann Hoeben, Melissa Kerkhof, Johan Kros, Sieger Leenstra, Guiseppe Lombardi, Slávka Lukacova, Pierre Robe, Juan M. Sepulveda, Walter Taal, Martin Taphoorn, Annemiek M.E. Walenkamp, Colin Watts, Michael Weller, Filip Y.F. de Vos, Martin van den Bent, Pim French
Publikováno v:
WFNOS 2022 Abstract Book.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a21ef110a7c59f388375c8ccc9523928
https://doi.org/10.14791/btrt.2022.10.f-1098
https://doi.org/10.14791/btrt.2022.10.f-1098
Autor:
Youri Hoogstrate, Kaspar Draaisma, Santoesha A. Ghisai, Iris de Heer, Levi van Hijfte, Wouter Coppieters, Melissa Kerkhof, Astrid Weyerbrock, Marc Sanson, Ann Hoeben, Slávka Lukacova, Giuseppe Lombardi, Sieger Leenstra, Monique Hanse, Ruth Fleischeuer, Colin Watts, Joseph McAbee, Nicos Angelopoulos, Thierry Gorlia, Vassilis Golfinopoulos, Johan M. Kros, Vincent Bours, Martin J. van den Bent, Pierre A. Robe, Pim J. French
Publikováno v:
Cancer Research. 82:6140-6140
Background: Glioblastoma is the most prevalent and severe type of malignant brain tumor in adults. Although the genetic make-up initiating glioblastoma is increasingly better understood, a better understanding in the mechanisms that drive its evoluti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfb2abdf8f1981e52ef74540bb7c6791
https://doi.org/10.1158/1538-7445.am2022-6140
https://doi.org/10.1158/1538-7445.am2022-6140
Autor:
Thierry Gorlia, Vincent Bours, Colin Watts, Roel G.W. Verhaak, Johan M. Kros, Giuseppe Lombardi, Sieger Leenstra, Pierre A. Robe, Joseph H. McAbee, Marc Sanson, Melissa Kerkhof, Nicos Angelopoulos, Martin J B Taphoorn, Pim J. French, Ann Hoeben, Ultan McDermott, Ruth Fleischeuer, Monique Hanse, Slavka Lukacova, Vassilis Golfinopoulos, Kaspar Draaisma, Martin J. van den Bent, Astrid Weyerbrock, Aikaterini Chatzipli
Publikováno v:
Journal of Clinical Oncology, 38(1), 81-99. American Society of Clinical Oncology
Draaisma, K, Chatzipli, A, Taphoorn, M, Kerkhof, M, Weyerbrock, A, Sanson, M, Hoeben, A, Lukacova, S, Lombardi, G, Leenstra, S, Hanse, M, Fleischeuer, R, Watts, C, McAbee, J, Angelopoulos, N, Gorlia, T, Golfinopoulos, V, Kros, J M, Verhaak, R G W, Bours, V, van den Bent, M J, McDermott, U, Robe, P A & French, P J 2020, ' Molecular evolution of IDH wild-type glioblastomas treated with standard of care affects survival and design of precision medicine trials : A report from the EORTC 1542 study ', Journal of Clinical Oncology, vol. 38, no. 1, pp. 81-99 . https://doi.org/10.1200/JCO.19.00367
Journal of Clinical Oncology, 38, 81-99. American Society of Clinical Oncology
Draaisma, K, Chatzipli, A, Taphoorn, M, Kerkhof, M, Weyerbrock, A, Sanson, M, Hoeben, A, Lukacova, S, Lombardi, G, Leenstra, S, Hanse, M, Fleischeuer, R, Watts, C, McAbee, J, Angelopoulos, N, Gorlia, T, Golfinopoulos, V, Kros, J M, Verhaak, R G W, Bours, V, van den Bent, M J, McDermott, U, Robe, P A & French, P J 2020, ' Molecular evolution of IDH wild-type glioblastomas treated with standard of care affects survival and design of precision medicine trials : A report from the EORTC 1542 study ', Journal of Clinical Oncology, vol. 38, no. 1, pp. 81-99 . https://doi.org/10.1200/JCO.19.00367
Journal of Clinical Oncology, 38, 81-99. American Society of Clinical Oncology
PURPOSE Precision medicine trials in glioblastoma (GBM) are often conducted at tumor recurrence. However, second surgeries for recurrent GBM are not routinely performed, and therefore, molecular data for trial inclusion are predominantly derived from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b889fbf7ea028fbd02206bb8ba440f70
https://cris.maastrichtuniversity.nl/en/publications/04973a2e-30ee-445c-8029-685ab2b01a63
https://cris.maastrichtuniversity.nl/en/publications/04973a2e-30ee-445c-8029-685ab2b01a63
Autor:
Melissa Kerkhof, Linda Dirven, Maaike J. Vos, R. Wiggenraad, G. J. Lycklama à Nijeholt, Sebastiaan Hammer, I. Ganeff, Martin J B Taphoorn
Publikováno v:
Journal of Neuro-Oncology
To assess the applicability of perfusion-weighted (PWI) magnetic resonance (MR) imaging in clinical practice, as well as to evaluate the changes in PWI in brain metastases before and after stereotactic radiotherapy (SRT), and to correlate these chang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffc82b356fe25ecb75b662d5e1234f87
https://doi.org/10.1007/s11060-018-2779-7
https://doi.org/10.1007/s11060-018-2779-7
Autor:
Pauline L. Tans, Martin J B Taphoorn, Rogier E. Hagenbeek, Finn K. Holla, Melissa Kerkhof, Chiara S. M. Straathof, Linda Dirven, Maaike J. Vos, Tjeerd J. Postma, Geert J. Lycklama à Nijeholt
Publikováno v:
Kerkhof, M, Tans, P L, Hagenbeek, R E, Lycklama À Nijeholt, G J, Holla, F K, Postma, T J, Straathof, C S, Dirven, L, Taphoorn, M J & Vos, M J 2017, ' Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients ', CNS Oncology, vol. 6, no. 4, pp. 297-306 . https://doi.org/10.2217/cns-2017-0013
CNS Oncology, 6(4), 297-306. Future Medicine Ltd.
CNS Oncology, 6(4), 297-306. Future Medicine Ltd.
Aim: We examined whether visual interpretation of relative cerebral blood volume (rCBV) color maps made with dynamic susceptibility-weighted perfusion MRI can reliably distinguish progressive disease (PD) from pseudoprogression (PsPD) in glioblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b610735a34be169011821dd51eb1f4f4
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85050618755&origin=inward
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85050618755&origin=inward
Autor:
Kaspar, Draaisma, Aikaterini, Chatzipli, Martin, Taphoorn, Melissa, Kerkhof, Astrid, Weyerbrock, Marc, Sanson, Ann, Hoeben, Slávka, Lukacova, Giuseppe, Lombardi, Sieger, Leenstra, Monique, Hanse, Ruth, Fleischeuer, Colin, Watts, Joseph, McAbee, Nicos, Angelopoulos, Thierry, Gorlia, Vassilis, Golfinopoulos, Johan M, Kros, Roel G W, Verhaak, Vincent, Bours, Martin J, van den Bent, Ultan, McDermott, Pierre A, Robe, Pim J, French
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38(1)
Precision medicine trials in glioblastoma (GBM) are often conducted at tumor recurrence. However, second surgeries for recurrent GBM are not routinely performed, and therefore, molecular data for trial inclusion are predominantly derived from the pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f1496777c1e8164cbabb20e01d775e3e
https://pubmed.ncbi.nlm.nih.gov/31743054
https://pubmed.ncbi.nlm.nih.gov/31743054
Publikováno v:
Neuropraxis. 20:96-99
Het zal duidelijk zijn dat voor veel patienten een (wakkere) hersenoperatie voor een hersentumor een spannend en belastend vooruitzicht is. Met een wakkere tumorresectie kan zoveel mogelijk van de hersentumor verwijderd worden en kunnen tegelijkertij
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e438ee32ab2cfb5ad0c3b7a9c62052ce
https://doi.org/10.1007/s12474-016-0121-8
https://doi.org/10.1007/s12474-016-0121-8
Publikováno v:
CNS Oncology. 4:347-356
Epilepsy develops in more than 70–90% of oligodendroglial tumors and represents a favorable indicator for long-term survival if present as the first clinical sign. Presence of IDH1 mutation is frequently associated with seizures in oligodendrogliom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5414e8ceae5fdb7809b94d876ddd8511
https://doi.org/10.2217/cns.15.29
https://doi.org/10.2217/cns.15.29
Autor:
Jaap C. Reijneveld, Melissa Kerkhof, Linda Dirven, Jan J. Heimans, Johan A F Koekkoek, Martin J B Taphoorn
Publikováno v:
Koekkoek, J A F, Kerkhof, M, Dirven, L, Heimans, J J, Reijneveld, J C & Taphoorn, M J B 2015, ' Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review ', Neuro-Oncology, vol. 17, no. 7, pp. 924-934 . https://doi.org/10.1093/neuonc/nov032
Neuro-Oncology, 17(7), 924-934. Oxford University Press
Neuro-Oncology, 17(7), 924-934. Oxford University Press
There is growing evidence that antitumor treatment contributes to better seizure control in low-grade glioma patients. We performed a systematic review of the current literature on seizure outcome after radiotherapy and chemotherapy and evaluated the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1a3f68744e294f2d3e601e103528974
https://doi.org/10.1093/neuonc/nov032
https://doi.org/10.1093/neuonc/nov032